期刊
VACCINE
卷 27, 期 -, 页码 D56-D60出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2009.07.068
关键词
Pneumonic plague; Mechanisms of protection; Non-clinical; Clinical studies
Killed whole cell vaccines for plague were first produced as long ago as the late 1890s and modified versions of these are still used, with evidence that they are efficacious against bubonic plague. Renewed efforts with modern technology have yielded new candidate vaccines which are less reactogenic, can be produced in a conventional pharmaceutical manufacturing plant and are protective against the life-threatening pneumonic form of the disease. This paper reviews the progress towards an improved vaccine for plague and assesses the likely impact of a prophylactic vaccine for bubonic and pneumonic plague. Crown Copyright (C) 2009 Published by Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据